You are here
CAPS® Expands National Footprint, Opens New 503B Compounding Outsourcing Facility in Phoenix
New facility brings nearly 400 jobs and the latest engineering and technology in sterile compounding to the western U.S.
IRVINE, Calif., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Central Admixture Pharmacy Services, Inc. (CAPS), a B. Braun company and the nation’s largest network of outsourcing admixture pharmacies, has today opened a new sterile compounding outsourcing facility in Phoenix, bringing nearly 400 jobs to the area. CAPS' continued growth and investment in this new facility serves as the next milestone towards expanding the capacity of the sterile compounding industry across the U.S. The new 250,000 square foot facility positions Phoenix as a hub for 503B compounding, tripling CAPS' capacity and enhancing the ability for CAPS customers all over the country to provide high-quality, safe and readily-available products to patients who need it most.
The new facility embraces the most innovative technology and automation capabilities to deliver the highest quality products for its customers. With a focus on safety and quality, CAPS continues to provide products at the scale demanded by health systems that enable them to solve the challenges associated with regulations, recalls and drug shortages.
“As we continue to grow, our commitment to providing compounded sterile preparations of the highest quality that add value to our pharmacy service partners remains at the forefront of our company,” said Tom Wilverding, President at CAPS. “The investment in the new Phoenix facility furthers the track record of unprecedented quality and success that CAPS has always delivered to our 503B customers.”
CAPS has grown into a network of 22 503A regional pharmacies by constantly staying ahead of the high standards required to compound sterile preparations. The new Phoenix facility will serve as the third CAPS 503B Outsourcing Facility registered with the FDA, further demonstrating the company’s devotion to innovation and being a pioneer in the industry. When fully operational, it will bring job opportunities to the Phoenix and surrounding areas for pharmacists, pharmacy technicians, chemists, microbiologists, and other support personnel.
“We would like to thank the Arizona Commerce Authority and the City of Phoenix. The opening of the new CAPS facility is an example of the positive business environment that has been created in Arizona and the city of Phoenix,” said Bruce Heugel, Senior Vice President and Chief Financial Officer at B. Braun Medical Inc., an affiliate of CAPS. “CAPS considered a number of other locations but none as attractive as the Phoenix community. By taking a ‘regional approach’ to economic development, we are able to help create opportunities for growing jobs in the community.”
CAPS is the nation's largest network of outsourcing admixture pharmacies. A pioneer in the outsourcing of CSPs, CAPS was founded in 1991, and delivers high-quality, same-day, admixture services and solutions to hospitals and outpatient facilities across the nation. CAPS has three 503B Outsourcing Facilities that are registered with the FDA to provide anticipatory compounding services. CAPS also has 22 state licensed 503A regional pharmacies that dispense labeled, patient-specific prescriptions including PN and chemotherapy. To learn more, visit www.capspharmacy.com.